Navigation Links
Bernstein Liebhard LLP Launches Mirena IUD Lawsuit Website Providing Information on Side Effects, Growing Litigation
Date:1/19/2013

New York, NY (PRWEB) January 19, 2013

For women looking to pursue a Mirena IUD lawsuit, Bernstein Liebhard LLP has launched a new website providing the most up-to-date Mirena IUD lawsuit news, as well as details about side effects and what legal steps should be taken in filing a claim. This information is vital to anyone who suffered injuries after being implanted with the intrauterine birth control device manufactured by Bayer Healthcare Pharmaceuticals Inc.

The firm is also currently offering free and confidential case reviews to women whose Mirena IUD spontaneously migrated, leading to serious side effects such as:

  •     Organ Damage
  •     Abscesses
  •     Perforated Uterus
  •     Infertility
  •     Infection
  •     Intestinal obstruction or perforation
  •     Pelvic Inflammatory Disease
  •     Ectopic Pregnancy

“More and more young women who have suffered horrific injuries allegedly caused by the Mirena IUD have been reaching out to us about their legal options. Our firm’s new website will provide the updated information they need to learn about potential Mirena side effects, as well as the increasing amount of Mirena IUD lawsuits being filed by women around the U.S.,” says Bernstein Liebhard LLP, a nationwide law firm that represents the victims of defective drugs and medical devices, including the Mirena IUD.

Mirena IUD Lawsuits

The Mirena IUD is a t-shaped intrauterine device implanted into a woman’s uterus to prevent pregnancy for up to five years. Approved by the U.S. Food and Drug Administration (FDA) in 2000 as a method of contraception, Mirena’s approved uses were later expanded to include heavy menstrual bleeding in women who wish to use an IUD as their method of birth control. In 2009, the FDA sent a warning letter to Bayer after determining that the company’s promotion of Mirena overstated its efficacy and minimized its risks.*

A rising number of Mirena IUD lawsuits have already been brought by women who claim to have experienced the serious side effects associated with Mirena. Right now, at least 16 claims are pending in New Jersey Superior Court. Bayer Healthcare Pharmaceuticals filed a motion last August to consolidate the Mirena IUD lawsuits in New Jersey before a judge in Middlesex County, which was later denied.**

On January 16, 2013, plaintiffs filed a petition with the U.S. Judicial Panel for Multidistrict Litigation (JPML) to transfer all pending and future federally-filed Mirena lawsuits to the U.S. District Court, Northern District of Ohio for pretrial proceedings. The petition stated that eight lawsuits, which are pending in federal court, claim the Mirena IUD can migrate within a woman’s body once inserted and is designed defectively. The petition also asserted that hundreds of similar claims are likely to be filed over the Mirena IUD in the future.***

Young women who were implanted with the Mirena IUD and experienced migration of the device, uterine perforation and other severe injuries may be eligible to seek compensation for medical expenses, lost wages as well as any pain and suffering they may have been caused. For more information about Mirena side effects, visit Bernstein Liebhard LLP’s website,or contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.

*fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf
**judiciary.state.nj.us/mass-tort/mirena-app.pdf
***harrismartin.com/media/uploads/documents/DRU-1301-27.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/mirena-iud-lawsuit/mirena-side-effects/prweb10339950.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Da Vinci Surgery Robot Lawsuit Website Launched by Bernstein Leibhard LLP to Inform Public about Potential Da Vinci Surgery Complications
2. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
3. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
4. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
5. DePuy ASR Hip Recall, Transvaginal Mesh Lawsuit Updates: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trials in New Year
6. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
7. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
8. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
9. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
10. Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports
11. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... (NYLF): Medicine will have the unique opportunity to get hands-on experience in ... high school students an immersive experience to gain invaluable, real-life medical skills that ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand ... at the Icahn School of Medicine at Mount Sinai has found. The study ... young children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 Recovery Diaries (oc87recoverydiaries.com) recounts ... in a unique, personal perspective through animation. , That woman is Sheri ... at her private psychotherapy practice. Sheri’s mother, Pearl, lived with schizophrenia. , ...
(Date:12/7/2016)... , ... December 07, 2016 , ... It is vital ... is with useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, ... 'need for speed' and the need to operate in a GLP (Good Laboratory Practice) ...
(Date:12/7/2016)... ... 07, 2016 , ... Levels of a protein in the blood associated with ... online in the journal Radiology. , Heart disease and brain disease exact a major ... rapidly aging population. Damage to both organs often occurs at a subclinical stage, or ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... N.J., Dec. 8, 2016 CANTEL MEDICAL CORP. (NYSE: ... of $18,800,000, or $0.45 per diluted share, on a 22.1% ... quarter ended October 31, 2016. This compares with net income ... $153,779,000 for the first quarter ended October 31, 2015. ... quarter ended October 31, 2016 to $21,323,000, or $0.51 per ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... Dec. 7, 2016   IQuity, Inc., a ... Don Hardison has been appointed to ... executive with extensive experience as CEO, COO, and ... 500 companies within the molecular, clinical diagnostic, and ... and sales experience within the pharmaceutical industry. His ...
Breaking Medicine Technology: